Company Information

  

Address: 5421 AVENIDA ENCINAS
SUITE F 
City: San Diego 
State: CA 
Zip Code: 92008 
Telephone: 858-480-2400 

Description of Business

Primary SIC Code: 3841
(As filed with the SEC)  

BUSINESS OVERVIEW We are a vertically integrated medical device company focused on developing and commercializing innovative medical devices to treat obese and overweight people by facilitating weight loss. Our initial product offering is the Obalon balloon system, the first and only U.S. Food and Drug Administration, or FDA, approved swallowable, gas-filled intragastric balloon designed to provide progressive and sustained weight loss in obese patients. We believe the Obalon balloon system offers patients and physicians benefits over prior weight loss devices including, but not limited to: a favorable safety profile, improved patient tolerability and comfort, progressive weight loss with durable results, simple and convenient placement, and attractive economics for patients and physicians. In September 2016, we received premarket approval, or PMA, from the FDA, and commenced U.S. commercialization in January 2017.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/2018-2.32NAN/E
12/2017-2.08NAN/E
09/201712.03NA0.79
06/20177.59NA1.31
03/20170.90NA11.88
12/2016-4.85NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.24Total Liab/Total Assets0.34
Net Inc/Total Assets-0.65Total Liab/Inv Cap0.44
Net Inc/Inv Cap-0.85Total Liab/Comm Equity0.12
Pretax Inc/Net Sales-3.51Interest Coverage Ratio-256.52
Net Inc/Net Sales-3.51Curr Debt/Equity0.06
Cash Flow/Net Sales-3.09LTD/Equity0.23
SG&A/NetSales2.91Total Debt/Equity0.28
Asset Utilization   Liquidity  
Net Receivables Turnover4.18Quick Ratio5.03
Inventory Turnover4.30Current Ratio5.17
Inventory Day Sales0.01Net Rec/Curr Assets0.08
Net Sales/Work Cap0.24Inv/Curr Assets0.03
Net Sales/PP&E7.37  

Income Statement (Millions)

  3/31/2018 12/31/2017 9/30/2017 6/30/2017
Total Revenues(Net Sales) 1.35 3.69 2.79 1.96
Cost of Goods Sold 0.77 1.70 1.31 0.99
Selling & Admin Exps 10.01 9.22 7.81 5.85
Operating Income -12.07 -9.92 -9.14 -7.64
Interest Exp 0.04 0.03 0.02 0.04
Pretax Income -12.13 -10.12 -9.17 -7.73
Other Income -0.02 -0.17 -0.01 -0.06
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -12.13 -10.12 -9.17 -7.73

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Cash & Short Term Investments 33.48 44.40 53.37 60.73
Receivables - Total 2.55 4.22 2.52 1.76
Inventories - Total 1.87 1.42 0.91 0.75
Total Current Assets 39.09 51.76 57.80 63.93
Net Property, Plant & Equipment 1.42 1.35 1.27 1.04
Total Assets 40.51 53.10 59.08 64.98
Liabilities        
Accounts Payable 4.14 5.77 3.95 3.27
Debt in Current Liabilities 2.96 1.96 0.96 NA
Total Current Liabilities 9.11 10.01 6.58 4.82
Long-Term Debt 6.97 7.96 8.96 9.90
Total Liabilities 16.08 17.99 15.56 14.76
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.02 0.02 0.02 0.02
Retained Earnings -123.50 -111.37 -101.25 -92.08
Treasury Stock NA NA NA NA
Total Stockholders' Equity 24.42 35.11 43.52 50.22
Total Liabilities and Stockholders' Equity 40.51 53.10 59.08 64.98

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Net Cash Provided by Operating Activities -10.60 -9.20 -7.02 -6.06
Net Cash Provided by Investing Activities 22.94 17.87 13.27 -30.08
Net Cash Provided by Financing Activities 0.03 0.36 0.01 0.25

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20143.54-9.89--
12/20154.04-15.56--
12/20163.39-20.47-4.85
12/20179.91-34.76-2.08
Growth Rates40.97----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/18716,27035.68




Report Date : 7/9/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.